Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct 24;129(42):12795-800.
doi: 10.1021/ja073098r. Epub 2007 Oct 3.

Anomeric reactivity-based one-pot synthesis of heparin-like oligosaccharides

Affiliations

Anomeric reactivity-based one-pot synthesis of heparin-like oligosaccharides

Tülay Polat et al. J Am Chem Soc. .

Abstract

A highly efficient one-pot methodology is described for the synthesis of heparin and heparan sulfate oligosaccharides utilizing thioglycosides with well-defined reactivity as building blocks. L-Idopyranosyl and D-glucopyranosyl thioglycosides 5 and 10 were used as donors due to low reactivity of uronic acids as the glycosyl donors in the one-pot synthesis. The formation of uronic acids by a selective oxidation at C-6 was performed after assembly of the oligosaccharides. The efficiency of this programmable strategy with the flexibility for sulfate incorporation was demonstrated in the representative synthesis of disaccharides 17, 18, tetrasaccharide 23, and pentasaccharide 26.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic view of heparin
Scheme 1
Scheme 1
Preparation of the 1-thio uronic acid building blocks 5 and 10a aReagents and conditions: (a) TolSH, BF3·Et2O, 2: 93% (9:1 α/β), 7: 87%; (b) i. NaOMe, MeOH; ii. PhCH(OMe)2, p-TsOH, CH3CN/DMF; iii. BzCl, Pyridine; iv. 60% TFA in H2O, CH2Cl2, 3: 78%, 8: 81%; (c) TBDPSCl, Pyridine, 4: 91%, 9: 95%; d) Lev2O, Pyridine, 5: 89%, 10: 91%.
Scheme 2
Scheme 2
Preparation of azidoglucosyl acceptors 15 and 16a aReagents and conditions: (a) i. Bu2SnO, Toluene ii. Bu4NBr, BnBr, 65% in two steps; (b) PhCH(OMe)2, CSA, 89%; (c) i. Tf2O, Pyr-CH2Cl2, ii. NaN3, DMF, 83% in two steps; (d) i. 80% AcOH, ii. AcCl, Pyridine, 15: 89%; (e) PhBCl2, Et3SiH, CH2Cl2, 92%; (f) Ac2O, Pyridine, 16: 95%;
Scheme 3
Scheme 3
One-pot synthesis of disaccharide derivatives 1720 aReagents and conditions: (a) NIS, TfOH, CH2Cl2, -45°C to room temperature, 17: 92%, 18: 89%, 19: 96%; (b) BSP, Tf2O, CH2Cl2, -45°C to room temperature, 17: 72%, 18: 75%; (c) N-(phenylythio)-ε-caprolactam, Tf2O, CH2Cl2, -45°C to room temperature, 17: 85%, 18: 88%; (d) NH2NH2/AcOH/Pyridine, 20: 95%.
Scheme 4
Scheme 4
One-pot synthesis of tetrasaccharide derivative 23a aReagents and conditions: (a) NIS, TfOH, CH2Cl2, -45°C to room temperature, 35%; (b) HF·Pyr, THF, 87%; (c) i. TEMPO, KBr, NaOCl, CH2Cl2, H2O, ii. MeI, KHCO3, DMF, 68% in two steps.
Scheme 5
Scheme 5
One-pot synthesis of pentasaccharide derivative 27a aReagents and conditions: (a) i. HF·Pyr, THF; ii. TEMPO, KBr, NaOCl, CH2Cl2, H2O, then MeI, KHCO3, DMF; iii. NH2NH2/AcOH/Pyridine, 24: 45%, 25: 77%; (b) i. NIS, TfOH, CH2Cl2, -45°C to room temperature; ii. NIS, TfOH, CH2Cl2, -45°C to room temperature, 20%; c) i. LiOOH, THF; ii. Et3N·SO3, DMF; ii. H2, Pd/C; iv- Pyr·SO3, H2O, 33%.

Similar articles

Cited by

References

    1. Comper WD. Heparin and Related Polysaccharides. Vol. 1. Gordon and Breach; New York: 1981.
    2. Linhardt RJ, Toida T. In: Carbohydrates as Drugs. Witczak Z, Nieforth K, editors. Dekker; New York: 1998. pp. 277–341.
    1. Kjellen L, Lindahl U. Annu Rev Biochem. 1991;60:443. - PubMed
    2. Conrad HE. Heparin Binding Proteins. Academic Press; New York: 1998.
    3. Capila I, Linhardt RJ. Angew Chem Int Ed. 2002;41:390. - PubMed
    1. Koshida S, Suda Y, Sobel M, Ormsby J, Kusumoto S. Bioorg Med Chem Lett. 1999;9:3127. - PubMed
    2. Petitou M, Duchaussoy P, Driguez PA, Jaurand G, Herault JP, Lormeau JC, van Boeckel CAA, Herbert JM. Angew Chem Int Ed. 1998;37:3009. - PubMed
    3. Petitou M, Herault JP, Bernat A, Driguez PA, Duchaussoy P, Lormeau JC, Herbert JM. Nature. 1999;398:417. - PubMed
    1. Jacquinet JC, Petitou M, Duchaussoy P, Lederman I, Choay J, Torri G, Sinay P. Carbohydr Res. 1984;130:221.
    2. Sinay P, Jacquinet JC, Petitou M, Duchaussoy P, Lederman I, Choay J, Torri G. Carbohydr Res. 1984;132:C5.
    3. Van Boeckel CAA, Beetz T, Vos JN, De Jong AJM, Van Aelst SF, Van den Bosch RH, Mertens JMR, Van der Vlugt FA. Carbohydr Res. 1985;4:293.
    4. Ichikawa Y, Monden R, Kuzuhara H. Carbohydr Res. 1988;172:37. - PubMed
    1. Poletti L, Lay L. Eur J Org Chem. 2003:2999. and the references therein Noti C, Seeberger PH. Chem Biol. 2005;12:731. and the references therein Orgueira HA, Bartolozzi A, Schell P, Litiens REJN, Palmacci ER, Seeberger PH. Chem Eur J. 2003;9:140.Haller MF, Boons GJ. Eur J Org Chem. 2002:2033.de Paz JL, Ojeda R, Erichardt N, Martin-Lomas M. Eur J Org Chem. 2003;68:3308.Yu HY, Furukawa JI, Ikeda T, Wong CH. Org Lett. 2004;6:723.Lee JC, Lu XA, Kulkarni SS, Wen YS, Hung SC. J Am Chem Soc. 2004;126:476.Codee JDC, Stubba B, Schiattarella M, Overkleeft HS, van Boeckel CAA, van Boom JH, van der Marel GA. J Am Chem Soc. 2005;127:3767.Zhou Y, Lin F, Chen J, Yu B. Carbohydr Res. 2006;341:1619.Lu LD, Shie CR, Kulkarni SS, Pan GR, Lu XA, Hung SC. Org Lett. 2006;8:5995.

Publication types